Summary
Aspira Pathlab & Diagnostics share holding pattern reports the following shareholding: Aspira Pathlab & Diagnostics Total Promoters is at 18.39%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.00%, and Retail at 81.61%. This breakdown provides a quick snapshot of ownership distribution for Aspira Pathlab & Diagnostics share holding pattern in 2026-27.
Aspira Pathlab & Diagnostics FAQs
As of 05-2026, the promoter shareholding in Aspira Pathlab & Diagnostics stands at 18.39% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Aspira Pathlab & Diagnostics is 0% and 0% respectively.
The retail shareholding of the Aspira Pathlab & Diagnostics is 81.61%.
Changes in shareholding patterns of Aspira Pathlab & Diagnostics can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Aspira Pathlab & Diagnostics are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Aspira Pathlab & Diagnostics Associated Pages
- Aspira Pathlab & Diagnostics Share Price
- Aspira Pathlab & Diagnostics Share Price chart
- Aspira Pathlab & Diagnostics Fundamental Analysis
- Aspira Pathlab & Diagnostics Technical Analysis
- Aspira Pathlab & Diagnostics Peer Comparison
- Aspira Pathlab & Diagnostics Share Price History
- Aspira Pathlab & Diagnostics Board of Directors
